May 21-22, 2024 • Lugano Convention Centre (Palazzo dei Congressi), Lugano, Switzerland
Sustainability is now a business imperative. With the environmental bar set ever higher and investors’ expectations rising, sustainability is crucial for supplier selection and evaluation and a must for bio/pharmaceutical companies, CDMOs/CMOs, and other suppliers.
To address both the opportunities and challenges on this topic, the Drug, Chemical & Associated Technologies Association (DCAT) is bringing together high-level business executives and policy leaders for its inaugural two-day conference and networking event to provide specific, concrete, and innovative approaches to resolving sustainability challenges arising in the Bio/Pharmaceutical customer-supplier relationship.
DCAT’s Global Bio/Pharmaceutical Sustainability Imperative will answer that all-important; What do I need to know to stay informed and better understand how the competitive landscape is changing?
- Climate risks and financial reporting. Get an executive briefing on proposed and new climate-disclosure requirements in financial reporting in Europe and the United States. What does it mean for manufacturers and the supply chain?
- The European Green Deal. Hear from leading experts on the European Green Deal and the requirements for companies doing business in the EU and across borders. What does it mean for bio/pharma companies and their suppliers?
- Industry’s Challenges & Solutions. Gain practical insight from industry leaders on how their companies are managing risks, financial impacts, and challenges as they seek to meet their environmental targets. Learn how bio/pharma companies and their suppliers are tackling key issues: common data collection and reporting and best practices for sustainable sourcing. What are the key standards, metrics, and approaches being used in the industry: how will your company be measured?